The abnormal shape of the red blood cells of individuals with sickle cell disease prevents them passing easily through blood vessels, which can become obstructed, restricting blood flow to an organ and causing organ damage. New data, generated using a mouse model of SCD, have indicated that the drug bosentan prevents blood vessel obstruction and led to the suggestion that bosentan might be of benefit to individuals with SCD.